Next Generation

Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials

Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis…

by UsuarioZendal

MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG Vaccine

MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG Vaccine…

by UsuarioZendal

MTBVAC in new-borns Phase 2a trial completed its enrolment

MTBVAC in new-borns Phase 2a trial completed its enrolment…

by Natalia Desoños

Zendal is committed to the creation of a biotechnological pole Galicia-North of Portugal

Zendal is committed to the creation of a biotechnological pole Galicia-North of Portugal…

by desonhos

Privacy overview

At Zendal we use our own and third-party cookies. We use strictly necessary cookies to improve the performance of our website and analytics to collect information. This website does not use commercial or advertising cookies. By clicking "Accept" we consider that you accept their use. You can change the settings for the use of cookies by clicking on "Set cookies". These preferences may be modified at any time in the "Cookies Policy" section of our website. For more information on the use of cookies, you can consult our
Cookies policy

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
_GRECAPTCHA	5 months 27 days	This cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Next Generation

Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials

MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG Vaccine

MTBVAC in new-borns Phase 2a trial completed its enrolment

Zendal is committed to the creation of a biotechnological pole Galicia-North of Portugal

Cookie consent